Australian genomic life science company EZZ Life Science (ASX: EZZ) has won approval from the United States (US) Food and Drug Administration (FDA) for nine of its products in the food category, presenting a significant US expansion opportunity for EZZ. | ASX announcement: https://announcements.asx.com.au/asxpdf/20240625/pdf/064x2fh3lh72px.pdf
ZNO
0.065
66.7%
DUB
0.021
-44.7%
RLL
0.003
50%
CHM
0.005
-37.5%
DTR
0.052
40.5%
OFX
0.86
-34.6%
MM1
0.22
40.1%
DTZ
0.062
-28.7%
ALY
0.007
40%
CDEDC
0.005
-28.6%
ANR
0.007
40%
RDN
0.005
-28.6%
LTP
0.39
39.3%
EPX
0.021
-25%
CTO
0.004
33.3%
GTR
0.003
-25%
OVT
0.004
33.3%
DAL
0.023
-23.3%
ADO
0.009
28.6%
AUG
0.027
-20.6%
ATV
0.009
28.6%
ICG
0.004
-20%
LM1
0.165
26.9%
PHO
0.065
-18.8%
AVE
0.005
25%
PEK
0.275
-17.9%
KSN
0.115
25%
GBE
0.024
-17.2%
PPY
0.015
25%
FBR
0.005
-16.7%
RGL
0.005
25%
ARV
0.006
-14.3%
8CO
0.021
23.5%
AZL
0.006
-14.3%
JCS
0.033
22.2%
BLU
0.006
-14.3%
MRR
0.011
22.2%
ENL
0.03
-14.3%
MPK
0.6
21.2%
GLL
0.006
-14.3%
